Cargando…
Molecular docking studies of phytochemicals from Terminalia chebula for identification of potential multi-target inhibitors of SARS-CoV-2 proteins
BACKGROUND: The COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a global pandemic claiming more than 6 million lives worldwide as of 16 March 2022. Till date, no medicine has been developed which is proved to have 100% efficiency in combating against th...
Autores principales: | Sarkar, Arkaniva, Agarwal, Rushali, Bandyopadhyay, Boudhayan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847108/ https://www.ncbi.nlm.nih.gov/pubmed/35185301 http://dx.doi.org/10.1016/j.jaim.2022.100557 |
Ejemplares similares
-
Phytochemical Composition, Antioxidant Activity, and Neuroprotective Effect of Terminalia chebula Retzius Extracts
por: Chang, Chia Lin, et al.
Publicado: (2012) -
Hypocholesterolemic effect of Terminalia chebula fruit (Myrobalan) in mice
por: Rathore, H.S., et al.
Publicado: (2004) -
A Review on Potential Mechanisms of Terminalia chebula in Alzheimer's Disease
por: Afshari, Amir R., et al.
Publicado: (2016) -
The Chronic and Acute Toxicity of Traditional Medicines Containing Terminalia chebula
por: ARONGQIQIGE,, et al.
Publicado: (2023) -
Comparative study of the antioxidant and reactive oxygen species scavenging properties in the extracts of the fruits of Terminalia chebula, Terminalia belerica and Emblica officinalis
por: Hazra, Bibhabasu, et al.
Publicado: (2010)